# PIMAVANSERIN
> **ANDA214782** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2022-11-07
## Drug
- **FDA Application Number:** ANDA214782
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PIMAVANSERIN
- **Generic name:** Pimavanserin
- **Active ingredients:** PIMAVANSERIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AUROBINDO PHARMA LTD
- **First approval:** 2022-11-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214782)
---
*MORVS · CC0 1.0*